This also confirm the previous studies for that GPC3 is also up-regulated in the serum of hepatocellular carcinoma, which imply that GPC3 can be a biomarker for effective diagnosis of hepatocellular carcinoma. This evidence concerns the gene GPC3 and hepatocellular carcinoma.